STX — Shield Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Shield Therapeutics, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	R2021 December 31st	R2022 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	Interim Report
Standards:	—	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	9.78	4.14	2.94	12.1	3.4
Net Total Accounts Receivable
Net Total Receivables	1.96	1.15	0.656	1.77	7.01
Total Inventory
Prepaid Expenses
Total Current Assets	12.4	6.39	5.23	17.3	12.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.008	0.026	0.032	0.304	0.238
Net Intangible Assets
Total Assets	43.4	36.3	32.5	44.4	26.6
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.95	4.17	2.25	3.72	12.8
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities	2.95	4.17	2.25	3.72	20.1
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	40.4	32.1	30.3	40.7	6.54
Total Liabilities & Shareholders' Equity	43.4	36.3	32.5	44.4	26.6
Total Common Shares Outstanding